Home

Date register of trial

Trials for date register in the RPCEC

Date of Registration Public title Sponsor Statesort icon
25/09/2015 Seawater-Rhinitis-Children-Phase III UDEA Registered
08/07/2015 Racotumomab-alum for recurrent platimun-sensitive epithelial ovarian cancer CIM Registered
24/06/2015 SURFACEN in ARDS. Adults. Phase IV CENSA Registered
15/12/2015 Racotumomab-alum cancer vaccine for solid tumors in pediatric patients CIM Registered
15/08/2017 Phenamate in the treatment of prostate cancer SSA Registered
11/03/2016 Dermofural-diabetic foot ulcers CBQ Registered
05/09/2017 CIMAbior® in CD20-positive B-cell Non-Hodgkin Lymphoma CIM Registered
22/05/2020 VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2 FINLAY Registered
16/02/2017 Ozone-Therapy-Immunoglobulin A deficiency-adults and childrens-Phase II HGM Registered
02/12/2016 Abexol and Glucosamine/Chondroitin Sulphate in osteoarthritis: study of the 6 months. CPN Registered
28/11/2016 Abexol and Atorvastatin in the non alcoholic steatohepatitis CPN Registered
22/04/2016 NAcGM3/VSSP-aids-patients drug resistant to antiretroviral treatment-Phase I-II CIM Registered
05/05/2020 Therapy for COVID-19-Phase I-II SSA Registered
19/11/2015 EFFECTIVENESS AND SAFETY IN GENERIC ABACAVIR/LAMIVUDINE AND EFAVIRENZ IN HIV NAIVE PATIENTS CLS Registered
29/10/2021 Retrospective observational study of the administration of Jusvinza, for the management of COVID-19 at the Hospital “Dr. Luis Diaz Soto”. CIGB Registered
01/02/2016 Determination of the local inflammatory response in patients with COPD by wood smoke and COPD per cigarette FNC Registered
30/06/2016 Nimotuzumab inoperable esophageal epithelial tumors, Phase IV CIM Registered
01/02/2016 CIGB-370 in patients with malignant tumors CIGB Registered
12/11/2021 Nasalferon in COVID-19 CIGB Registered
17/10/2017 Bioequivalence of Clopidogrel CIDEM Registered